Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes [0.03%]
一举两得：用于治疗二型糖尿病的双受体激动剂疗法
Ryan J Jalleh,Christopher K Rayner,Karen L Jones et al.
Ryan J Jalleh et al.
Talha Burki
Talha Burki
Luis M Ruilope,Gema Ruiz-Hurtado
Luis M Ruilope
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis [0.03%]
基于个体参与者数据的降压治疗降低糖尿病患者和非糖尿病患者主要心血管疾病风险的meta分析
Milad Nazarzadeh,Zeinab Bidel,Dexter Canoy et al.
Milad Nazarzadeh et al.
Background: Controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. We aimed to investigate the effects of blood pressure-lowerin...
Leonardo Trasande
Leonardo Trasande
Hyperglycaemia management in non-critical care settings: guidelines in focus [0.03%]
非重症监护室高血糖管理指南解读
Mark E Molitch
Mark E Molitch
Perceptions of alternative methods of insulin storage: an ethical dilemma [0.03%]
关于胰岛素存储替代方案的伦理困境及其看法
Arunkumar R Pande,Ashwani Kumar Thakur
Arunkumar R Pande
Blood glucose targets in the critically ill: is one size fits all still appropriate? [0.03%]
重症患者血糖目标值：一刀切的目标设定是否仍然适用？
James S Krinsley,Michael Brownlee,Michael W Schwartz et al.
James S Krinsley et al.
Madelung's disease in a rare 14th century Franco-Flemish woolen tapestry [0.03%]
罕见的十四世纪法兰德斯挂毯上的马德尔龙病患者
Andreas G Nerlich,Antonio Perciaccante,Simon T Donell et al.
Andreas G Nerlich et al.
Antonio Bernabe-Ortiz,Rodrigo M Carrillo-Larco
Antonio Bernabe-Ortiz